Titanium Oxide Nanoparticles Improve the Chemotherapeutic Action of Erlotinib in Liver Cancer Cells-Reference-Cited by-同舟云学术

Titanium Oxide Nanoparticles Improve the Chemotherapeutic Action of Erlotinib in Liver Cancer Cells

Published:2020-11-20 Issue:4 Volume:16 Page:337-343
ISSN:1573-3947
Container-title:Current Cancer Therapy Reviews
language:en
Short-container-title:CCTR

Author:

Abdel-Ghany Shaimaa E.¹,El-Sayed Eman¹,Ashraf Nour¹,Mokhtar Nada¹,Alqosaibi Amany²,Cevik Emre³,Bozkurt Ayhan⁴,Mohamed Eman W.⁵,Sabit Hussein³^ORCID

Affiliation:

1. Department of Environmental Biotechnology, College of Biotechnology, Misr University for Science and Technology, P.O. Box 77, Giza, Egypt

2. Department of Biology, College of Science, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, 31441 Dammam, Saudi Arabia

3. Department of Genetics, Institute for Medical Research and Consultations, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, 31441 Dammam, Saudi Arabia

4. Department of Physics, Institute for Medical Research and Consultations, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, 31441 Dammam, Saudi Arabia

5. College of Science, Hafr Al Batin University, Hafr Al Batin, Saudi Arabia

Abstract

Background: Hepatocellular carcinoma is the second leading cause of cancer-related deaths among other types of cancer due to lack of effective treatments and late diagnosis. Nanocarriers represent a novel method to deliver chemotherapeutic drugs, enhancing their bioavailability and stability. Methods: In the present study, we loaded gold nanoparticles (AuNPs) and titanium oxide nanoparticles (TiO2NPs) with ERL to investigate the efficiency of the formed composite in inducing apoptosis in HepG2 liver cancer cells. Cytotoxicity was assessed using MTT assay and cell phase distribution was assessed by flow cytometry along with apoptosis detection. Results: Data obtained indicated the efficiency of the formed composite to significantly induce cell death and arrest cell cycle and G2/M phase. IRF4 was downregulated after treatment with loaded ERL. Conclusion: Our data showed that loading ERL on TiO2NPs was more efficient than AuNPs. However, both nanocarriers were efficient compared with control.

Publisher

Bentham Science Publishers Ltd.

Subject

Cancer Research,Oncology,Molecular Medicine

Reference30 articles.

1. Balogh J.; Victor D.; Asham E.H.; Hepatocellular carcinoma: A review. J Hepatocell Carcinoma 2016,3,41-53

2. Rasool M.; Rashid S.; Arooj M.; New possibilities in hepatocellular carcinoma treatment. Anticancer Res 2014,34(4),1563-1571

3. Schacher-Kaufmann S.; Pless M.; Acute fatal liver toxicity under erlotinib. Case Rep Oncol 2010,3(2),182-188

4. Zhang J.; Zong Y.; Xu G.Z.; Xing K.; Erlotinib for advanced hepatocellular carcinoma. A systematic review of phase II/III clinical trials. Saudi Med J 2016,37(11),1184-1190

5. Rohr-Udilova N.; Klinglmüller F.; Seif M.; Oxidative stress mediates an increased formation of vascular endothelial growth factor in human hepatocarcinoma cells exposed to erlotinib. Oncotarget 2017,8(34),57109-57120

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A physicochemical and spectroscopic characterization of novel erlotinib conjugates with platinum nanoparticles;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2022-12

2. Clove (Syzygium aromaticum)-mediated metallic nanoparticles: Synthesis, characterization, and possible pharmacological and industrial applications;Clove ( Syzygium Aromaticum);2022